Protection of animals against soman (1,2,2-trimethylpropyl methylphosphono-fluoridate) by pretreatment with some other organophosphorus compounds, followed by oxime and atropine

Biochem Pharmacol. 1971 Jan;20(1):125-34. doi: 10.1016/0006-2952(71)90478-3.
No abstract available

MeSH terms

  • Amitriptyline / therapeutic use
  • Animals
  • Atropine / therapeutic use*
  • Bromides
  • Carbamates / therapeutic use
  • Cholinesterase Inhibitors / therapeutic use
  • Diphosphates / therapeutic use
  • Drug Antagonism
  • Female
  • Fluorine / therapeutic use
  • Guinea Pigs
  • Hydroxamic Acids / therapeutic use
  • Isoflurophate / therapeutic use
  • Lethal Dose 50
  • Nitrates
  • Nitrophenols / therapeutic use
  • Nitroso Compounds / therapeutic use
  • Organophosphonates / therapeutic use
  • Organophosphonates / toxicity*
  • Organophosphorus Compounds / therapeutic use
  • Orphenadrine / therapeutic use
  • Oximes / therapeutic use*
  • Parasympatholytics / therapeutic use
  • Physostigmine / therapeutic use
  • Poisoning / drug therapy
  • Pyridinium Compounds / therapeutic use
  • Rabbits
  • Rats
  • Salicylates / therapeutic use
  • Scopolamine / therapeutic use
  • Species Specificity
  • Sulfonic Acids / therapeutic use
  • Sulfuric Acids / therapeutic use
  • Thiazoles / therapeutic use
  • Time Factors

Substances

  • Bromides
  • Carbamates
  • Cholinesterase Inhibitors
  • Diphosphates
  • Hydroxamic Acids
  • Nitrates
  • Nitrophenols
  • Nitroso Compounds
  • Organophosphonates
  • Organophosphorus Compounds
  • Oximes
  • Parasympatholytics
  • Pyridinium Compounds
  • Salicylates
  • Sulfonic Acids
  • Sulfuric Acids
  • Thiazoles
  • Isoflurophate
  • Amitriptyline
  • Fluorine
  • Atropine
  • Physostigmine
  • Orphenadrine
  • Scopolamine